Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €44.64 EUR
Change Today +1.08 / 2.48%
Volume 0.0
THC1 On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 3:38 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

tenet healthcare corp (THC1) Snapshot

Open
€43.85
Previous Close
€43.56
Day High
€44.65
Day Low
€43.36
52 Week High
07/15/15 - €55.30
52 Week Low
11/17/14 - €36.61
Market Cap
4.4B
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
99.6M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for TENET HEALTHCARE CORP (THC1)

tenet healthcare corp (THC1) Details

Tenet Healthcare Corporation, a healthcare services company, primarily operates acute care hospitals and related healthcare facilities in the United States. It operates through two segments, Hospital Operations and Other, and Conifer. The company’s general hospitals offer acute care services, operating and recovery rooms, radiology services, respiratory therapy services, clinical laboratories, and pharmacies. It also provides intensive care, critical care and/or coronary care units, physical therapy, orthopedic, oncology, and outpatient services; tertiary care services, including open-heart surgery, neonatal intensive care, and neurosciences; quaternary care services in the areas of heart, liver, kidney, and bone marrow transplants; quaternary pediatric and burn services; advanced treatment options for patients; gamma-knife brain surgery; cyberknife radiation therapy for tumors and lesions in the brain, lung, neck, and spine; and outpatient services. In addition, the company offers clinical research programs related to cardiovascular disease, pulmonary disease, musculoskeletal disorders, neurological disorders, genitourinary disease, and various cancers, as well as drug and medical device studies. Further, it provides operational management for patient access, health information management, revenue integrity, and patient financial services; communications and engagement solutions to optimize the relationship between providers and patients; and management services comprising clinical integration, financial risk management, and population health management. As of July 15, 2015, the company operated 81 general acute care hospitals, 18 short-stay surgical hospitals, and approximately 400 outpatient centers in the United States; and 9 facilities in the United Kingdom. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.

83,160 Employees
Last Reported Date: 02/23/15
Founded in 1967

tenet healthcare corp (THC1) Top Compensated Officers

Chairman, Chief Executive Officer, President ...
Total Annual Compensation: $1.3M
Chief Financial Officer
Total Annual Compensation: $565.9K
President of Hospital Operations
Total Annual Compensation: $690.6K
Vice Chairman
Total Annual Compensation: $700.0K
Senior Vice President and General Counsel
Total Annual Compensation: $459.6K
Compensation as of Fiscal Year 2014.

tenet healthcare corp (THC1) Key Developments

HealthTrust Signs National Chain Tenet Healthcare to Contract

HealthTrust has signed national chain Tenet Healthcare to a contract. HealthTrust announced that it will provide its supply chain cost management services to the hospital chain for five years. HealthTrust beat out MedAssets for the contract but Tenet will continue to use MedAssets for revenue cycle management services.

Tenet Healthcare Eyes Acquisitions

Tenet Healthcare Corp. (NYSE:THC) is seeking acquisitions. Trevor Fetter, Chairman and Chief Executive Officer of Tenet Healthcare said, "We look forward to expanding these relationships through acquisitions and development opportunities, and we also believe USPI remains very well positioned to add new health system partners. For example, Dignity and Ascension are both very important partners of USPI and we are pleased to deepen our relationship with these two outstanding organizations through the Carondelet transaction I mentioned earlier."

Tenet Healthcare Corporation Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015; Provides Earnings Guidance for the Third Quarter of Fiscal 2015; Revises Earnings Guidance for the Full Year Ending December 31, 2015

Tenet Healthcare Corporation announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported net operating revenues of $4,492 million compared to $4,038 million a year ago. Operating income was $164 million compared to $207 million a year ago. Net loss from continuing operations, before income taxes was $54 million compared to profit of $17 million a year ago. Net loss attributable to the company's common shareholders was $61 million compared to $26 million a year ago. Loss per diluted share was $0.61 compared to $0.27 a year ago. Capital expenditures were $175 million compared to $242 million a year ago. Adjusted EBITDA was $568 million compared to $460 million a year ago, which included $16 million from USPI and Aspen for the last 2 weeks in June. Excluding these earnings, the company delivered EBITDA of $552 million. The majority of the company’s revenue growth was driven by a 2.3% increase in same-hospital adjusted patient admissions, a 4.5% increase in same-hospital net patient revenue per adjusted patient admission, and a $28 million increase in revenue at Conifer from non-Tenet customers, representing a growth rate of 19.0%. The company generated adjusted net income from continuing operations of $76 million, or $0.75 per diluted share, in the second quarter of 2015. This excludes $136 million, or $1.35 per share, in after-tax impairment charges, restructuring charges, acquisition-related costs, and litigation and investigation costs. The company generated adjusted net income from continuing operations of $17 million, or $0.17 per diluted share, in the second quarter of 2014, excluding the comparable items that totaled $27 million after-tax, or $0.28 per share. Adjusted net cash provided by operating activities from continuing operations was $467 million against $318 million a year ago. Purchases of property and equipment from continuing operations were $175 million against $242 million a year ago. For the six months, the company reported net operating revenues of $8,916 million compared to $7,963 million a year ago. Operating income was $454 million compared to $377 million a year ago. Net income from continuing operations, before income taxes was $37 million compared to $5 million a year ago. Net loss attributable to the company's common shareholders was $14 million compared to $58 million a year ago. Loss per diluted share was $0.14 compared to $0.60 a year ago. Net cash provided by operating activities was $353 million compared to $247 million a year ago. Purchases of property and equipment continuing operations was $359 million compared to $523 million a year ago. Capital expenditures was $359 million compared to $523 million a year ago. Adjusted EBITDA was $1,097 million compared to $847 million a year ago. The year-over-year revenue growth also benefitted from acquisitions, joint ventures and newly constructed facilities. Adjusted net cash provided by operating activities from continuing operations was $447 million against $343 million a year ago. Purchases of property and equipment from continuing operations were $359 million against $523 million a year ago. The company generated EBITDA growth of $108 million or 23% compared to last year. This performance was driven by a combination of same-hospital volume growth and pricing, the recognition of $45 million in California Provider Fee revenues and 36% EBITDA growth by Conifer. The company revised earnings guidance for the third quarter and full year ending December 31, 2015. During 2015, the company expects to generate net operating revenues of $18.1 billion to $18.5 billion, adjusted EBITDA of $2.225 billion to $2.325 billion, adjusted free cash flow of $225 million to $425 million, and adjusted earnings per share of $1.32 to $2.21. This includes approximately $65 million of electronic health record incentives. Net cash provided by operating activities of $1,119 million to $1,229 million. Adjusted net cash provided by operating activities from continuing operations of $1,225 million to $1,325 million. Purchases of property and equipment from continuing operations of $1,000 million to $900 million. Adjusted free cash flow from continuing operations of $225 million to $425 million. At the midpoint of the range, the pro forma EBITDA margins for 2015 would have been 13.1%, up 110 basis points from the guidance provided earlier this year. In the third quarter of 2015, the company expects to generate net operating revenues of $4.65 billion to $4.85 billion, Adjusted EBITDA of $550 million to $600 million and Adjusted earnings per share of $0.05 to $0.49. This includes approximately $8 million of electronic health record incentives.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
THC1:GR €44.64 EUR +1.08

THC1 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Amsurg Corp $80.06 USD -0.33
Community Health Systems Inc $54.97 USD +0.67
LifePoint Health Inc $80.09 USD -0.28
Magellan Health Inc $57.24 USD +0.85
Universal Health Services Inc $140.37 USD -0.60
View Industry Companies
 

Industry Analysis

THC1

Industry Average

Valuation THC1 Industry Range
Price/Earnings 89.2x
Price/Sales 0.3x
Price/Book 6.2x
Price/Cash Flow 5.5x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TENET HEALTHCARE CORP, please visit www.tenethealth.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.